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Abstract	Congestive heart failure (CHF) is a major cause of morbidity and mortality. Early diagnosis of CHF in
patients presenting to the emergency department with undifferentiated dyspnea would allow clinicians
to begin appropriate treatment more promptly. Current guidelines recommend B-type natriuretic
peptide (BNP) levels for more accurate diagnosis of CHF in dyspneic patients. Although BNP levels
are relatively inexpensive, the test is not usually performed at bedside and results may take up to an
hour or more. BNP also may have a “gray zone” in which the values can neither confirm nor rule out
CHF. BNP has a reported sensitivity of 87% and specificity of 74% at a cutoff of 400 pg/ml. Studies
investigating bedside ultrasound inferior vena cava (IVC) measurements for identifying CHF report a
specificity of 84% to 96% and sensitivity values ranging from 37% to 93%, depending on the study.
Given that ultrasound IVC measurements are performed at bedside and results are available rapidly,
it is reasonable to evaluate whether ultrasound IVC measurements obtained by appropriately trained
emergency department clinicians, alone or in combination with BNP, may increase diagnostic accuracy
of CHF. (J Patient Cent Res Rev. 2016;3:230-234.)
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Clinical Question
In adults, 18 years of age and older, who present to
the emergency department (ED) with dyspnea, are
inferior vena cava (IVC) measurements using bedside
ultrasound as accurate as B-type natriuretic peptide
(BNP) levels for identifying heart failure?
Brief Answer
Yes. Bedside ultrasound measurement of the IVC is
a highly specific and rapid tool for diagnosing heart
failure in the ED setting compared with BNP. BNP
costs less than bedside ultrasound but is less specific
and may take up to one hour or more at a clinical
juncture when rapid detection of volume overload
can rule in or rule out heart failure. In the studies
reviewed, the specificity of the IVC measurement was
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as good as, or better than, BNP values. Ultrasound IVC
measurements may be especially useful for cases in
which BNP values fall into a nondiagnostic “gray zone”
range. Based on current evidence, it seems reasonable
to conclude that ultrasound IVC measurements,
taken by properly trained ED clinicians, alone or in
combination with BNP, would likely increase accuracy
of diagnosing heart failure, allow earlier initiation of
appropriate treatment and potentially reduce morbidity
and mortality.
Date of Literature Search: March/April 2016.
Level of Evidence: B.
Search Terms
Ultrasound, heart failure, inferior vena cava, pro-Btype natriuretic peptide, NR-PRoBNP, emergency
department, diagnosis
Inclusion Criteria
Current systematic reviews, meta-analyses, cohort
studies, clinical research trials investigating the
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efficacy of ultrasound measurements of the IVC for
diagnosing heart failure in the ED.
Exclusion Criteria
Children less than 18 years of age, renal failure,
dialysis, mechanical ventilation, trauma, abdominal
surgery within two weeks, pregnancy.
Summary of Issues
In 2003, congestive heart failure (CHF) affected more
than 5.7 million adults in the United States, with a
lifetime incidence of 1 in 5 for individuals over age 40
years.1 Heart failure has a mortality rate of 19% and
is the primary hospital discharge diagnosis for adults
over age 65. As the Baby Boomer generation continues
to age, the American Heart Association estimates that
550,000 new cases of heart failure will be diagnosed
each year at an estimated cost of $27 billion annually.2
Approximately 80% of hospitalized heart failure patients
are admitted from the ED. Current clinical guidelines
recommend taking BNP levels to improve diagnostic
accuracy of CHF in patients who present to the ED
with undifferentiated dyspnea. BNP is a 32-amino acid
polypeptide secreted by the ventricles of the heart in
response to excessive stretching of heart muscle cells. A
normal level (< 100 pg/ml) rules out acute heart failure
and an elevated level (> 500 pg/ml) in the absence of
renal failure can be diagnostic.2 A study evaluating the
efficacy of BNP in correctly diagnosing CHF reported a
sensitivity of 96% and specificity of 26% at a cutoff level
of 100 pg/ml; at a cutoff level of 400 pg/ml, BNP had
a sensitivity of 87% and specificity of 74%.3 However,
BNP levels can have a “gray zone” in which the values
neither confirm nor rule out CHF. In addition, BNP
levels are not generally done at the bedside and results
can take up to an hour at a time when rapid recognition
of volume overload is critical for early treatment.1
Ultrasound IVC measurements, performed at bedside
in the ED, are rapid and potentially more specific for
diagnosing CHF. Measuring the IVC also may be more
accurate for identifying alternative causes of dyspnea,
such as pneumonia, chronic obstructive pulmonary
disease (COPD), noncardiogenic pulmonary edema
and lung cancer.4 This brief report examines the
evidence for using bedside ultrasound IVC, alone or
in addition to BNP, for accurately identifying heart
failure versus other causes of dyspnea.
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Summary of the Evidence
Studies show that bedside ultrasound measurements
of the IVC correlate with central venous pressure and
response to fluid administration. A small IVC (< 2
cm in diameter), with collapse greater than 50% on
inspiration, corresponds to a central venous pressure <
10 cm of water, and vice versa.4 Published guidelines
by the American Society of Echocardiography support
the evaluation of IVC size and collapsibility in the
assessment of central venous pressure.1 Studies in
patients with heart failure used IVC measurements to
estimate elevated cardiac filling pressures.5
In 2009, Blehar et al. used IVC measurements to
identify CHF in a convenience sample of 46 adults
(age ≥ 18 years) who presented at the ED with the
complaint of dyspnea.6 Patients who had received a
liver transplant, were on mechanical ventilation, taking
diuretics, bronchodilators or vasoactive medications, or
who were pregnant were excluded. Study participants
received ultrasound IVC measurements using a 3.5 MHz
curvilinear probe at bedside prior to any interventions.
Minimum diameter during inspiration and maximum
diameter during expiration were measured. Variation
was calculated as the difference between maximum
and minimum divided by the maximum. Patients
with CHF should have less variation in IVC diameter
because volume overload does not allow as much IVC
collapse as normally occurs during inspiration. Two
physicians, blinded to the ultrasound results, used a
standardized chart review to retrospectively determine
the final diagnosis as CHF or an alternate diagnosis.6
The study showed that respiratory variation of the
IVC was smaller in patients with CHF (9.6%) than
without CHF (46%).6 At the optimum cutoff value of
15% variation or less of the IVC diameter, the sensitivity
was 93% (95% confidence interval [CI]: 76–99) and the
specificity was 84% (95% CI: 77–88) for the diagnosis
of CHF (Table 1). Four participants who presented with
shortness of breath and BNP measurements > 100 pg/ml
were correctly identified by ultrasound IVC measurements
as non-CHF. The main limitations of this study were its
small study size and the lack of echocardiogram to rule
out confounding factors like tricuspid regurgitation.6
In 2012, Miller et al. determined the sensitivity and
specificity of a caval index for diagnosing acute
heart failure in 89 adults (age ≥ 50 years), who
www.aurora.org/jpcrr
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Table 1. Sensitivity and Specificity of IVC Measurements for Diagnosing Congestive Heart Failure
IVC-CI diameter
variation cutoff

Sensitivity
(95% CI)

Specificity
(95% CI)

Blehar et al.6 (N=46)

<15%

93% (76–99)

84% (77–88)

Miller et al.5 (N=89)

<15%
<33%

37% (22–55)
80% (63–91)

96% (86–99)
81% (68–90)

Anderson et al.1 (N=101)

<20%

52% (38–67)

86% (77–95)

Yamanoğlu et al.7 (N=74)

<50.5%

84% (60–90)

91% (79–98)

Study (number of subjects)

CI, confidence interval; IVC-CI, inferior vena cava collapsibility index.

presented at the ED with undifferentiated dyspnea.5
Patients were excluded if they required mechanical
ventilation, experienced recent trauma, had abdominal
surgery within the past two weeks, had known portal
hypertension or were pregnant. Two physicians took
ultrasound measurements with a cardiac phased-array
probe of the maximum IVC during expiration and the
minimum IVC during inspiration over three respiratory
cycles prior to any interventions. A caval index was
calculated as the difference between the IVC during
expiration and inspiration divided by the IVC during
expiration multiplied by 100 (IVCe − IVCi)/(IVCe ×
100). This study found that a caval index of < 15%
had a sensitivity of 37% (95% CI: 22–55) and a
specificity of 96% (95% CI: 86–99); at a caval index
of 33%, the sensitivity was 80% (95% CI: 63–91)
and the specificity was 81% (95% CI: 68–90) (Table
1). A limitation of this study for the purposes of this
review is that the diagnostic characteristics of BNP
were reported but not directly compared to ultrasound
measurements. The main limitation of this study was
its small sample size.5

At a cutoff point of 20%, the IVC-CI had a sensitivity
of 52% (95% CI: 38–67) and a specificity of 86%
(95% CI: 77–95) for accurately diagnosing acutely
decompensated heart failure (Table 1), similar to the
specificity of BNP levels > 500 pg/ml (83% [95% CI:
67–92]).1 When IVC-CI measurements were combined
with both LVEF and lung B-lines, the specificity went
up to 100% (95% CI: 92–100). These results suggest
that ultrasound tests measuring IVC-CI, LVEF and
lung B-lines may be the most accurate and effective
means of diagnosing heart failure at bedside. This study
was limited by its smaller size and possible selection
bias from the convenience sampling methodology.
There may have been some misclassifications based
on the retrospective chart review and potential bias
introduced by other test values recorded in charts from
prior non-ED encounters. For example, a smaller IVCCI variability may have been recorded because a low
ejection fraction was already noted in the chart.1

In a 2013 study, Anderson and colleagues investigated
the accuracy of IVC collapsibility index (IVC-CI),
left ventricular ejection fraction (LVEF) and lung
B-lines measured by ultrasound for diagnosing
acutely decompensated heart failure in the ED.1
The prospective convenience cohort study enrolled
101 adults (age ≥ 18 years) who presented at the ED
with acute dyspnea. BNP levels were ordered for
all study participants. Clinical investigators, who
were emergency ultrasound fellowship-trained and
blinded to all clinical data, performed the ultrasound
measurements of the IVC maximum and minimum,
LVEF and lung B-lines. These measurements were
compared to a final diagnosis as determined by chart

In a 2014 prospective, observational study, Yamanoğlu
et al. used IVC diameter measurements to differentiate
between dyspnea of cardiac origin and pulmonary
dyspnea.7 Inclusion criteria were met by 74 elderly
adults (mean age: 72.8 years) who presented to the ED
during the study time window. Patients with severe
tricuspid regurgitation, cardiac tamponade, aortic
dissection, abdominal surgery within the preceding
two weeks, or those who had cardiopulmonary
arrest, had been intubated or were pregnant were
excluded. Of the 74 enrolled patients, 32 received a
final diagnosis of cardiac-associated dyspnea. B-mode
IVC diameter greater than 9 mm during inspiration
had the greatest sensitivity (84.4%) and specificity
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review conducted by two emergency physicians
blinded to the ultrasound results.1

Topic Synopsis

(92.9%) for identifying dyspnea of cardiac origin;
IVC-CI was similar, with a sensitivity of 84.4% and
specificity 90.5% (Table 1). This study concluded that
ultrasound IVC measurements were “rapid, readily
available, inexpensive, reproducible techniques” for
differentiating dyspnea due to cardiac etiology (acute
heart failure) from dyspnea of pulmonary origin.7
Ultrasound technology is a common diagnostic
tool in the ED8 and is a required competency in all
U.S. Accreditation Council for Graduate Medical
Education emergency medicine programs.7,9 Bedside
ultrasound IVC measurement shows promise for use
in appropriately diagnosing CHF. Diagnostic accuracy
would be improved with standardization of the location
of IVC diameter measurement and probe orientation
(i.e. long vs short axis), which may vary depending
on training and experience of ED physicians.9 Reports
have documented the benefit of training targeting the
specific skills required for accurate performance and
reading ultrasound test results in the ED.10
Limitations
None of the studies reviewed in this report were
randomized controlled trials of efficacy. However,
a minority of studies of diagnostic tests meet this
standard. The four studies reported1,5-7 were prospective.
In three of the four,1,5,6 there was an independent blind
comparison with reference standards. All of the studies
used convenience samples, which increases the risk of
selection bias. However, the papers reviewed included
a broad spectrum of patients with characteristics
generalizable to the ED population. Small sample
sizes in each of the papers cited resulted in moderately
wide confidence intervals. Larger studies or a metaanalysis combining the data of several studies could
improve the precision of the estimates of sensitivity
and specificity of IVC-CI. However, a meta-analysis
may not be feasible due to differences in ultrasound
technique, study protocols and other potential causes of
study heterogeneity. Randomized controlled trials are
needed to evaluate the efficacy of bedside ultrasound
compared to BNP or the combination of BNP and
bedside ultrasound in the management of CHF.
Conclusions
Bedside ultrasound inferior vena cava measurements
in the presence of undifferentiated dyspnea in the
emergency department may be as helpful as, and
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more rapid than, B-type natriuretic peptide values for
diagnosing congestive heart failure. In the studies
reviewed, IVC-CI (ranging from 15% to 55.5%) had
a high specificity (84%–96%) for identifying heart
failure, which would allow ED physicians to avoid
prematurely treating patients who are not experiencing
CHF and revise their plan while collecting additional
data. In all instances, the specificity of ultrasound IVC
was as good as or better than BNP values and may help
achieve appropriate diagnosis for patients in which BNP
values fall in the “gray zone.” Bedside ultrasound IVC
assessment also may be useful for the early recognition
of other causes of dyspnea and comorbid conditions ––
such as COPD and other respiratory illnesses –– that
are increasing in prevalence among elderly patients.
Ultrasound IVC allows physicians to begin treating
even unstable patients earlier, before results from more
traditional tests like BNP become available.1
Now that the accuracy of bedside ultrasound has been
established, the next step would be undertaking studies
that evaluate the accuracy of ED physician-obtained
IVC measurements by ultrasound. Ideally, an ED
physician should be able to accurately and efficiently
assess noncollapsibility, as can be done for collapsibility,
by fluid resuscitation. If randomized controlled
trials demonstrate the efficacy of bedside ultrasound
compared to BNP in the management of CHF, costeffectiveness studies comparing diagnostic methods and
strategies should be undertaken to determine whether
the additional cost of ultrasound (~$264 vs ~$88 for
BNP, per Healthcare Bluebook mobile app) provides
significant improvements in diagnostic accuracy,
morbidity, mortality and quality of life.
Patient-Friendly Recap
• Heart failure is often diagnosed in the emergency
department using a specific blood test that takes
up to an hour to yield results.
• Bedside ultrasound technology, a common
diagnostic tool used in emergency departments,
has shown promise in measuring heart function.
• The authors reviewed findings from several
published studies and concluded that measuring
a patient’s inferior vena cava with ultrasound
may help quickly and accurately diagnose
congestive heart failure.
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